USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition

Importance of the Topic

Updates to both the United States Pharmacopeia General Chapter <857> and the European Pharmacopoeia Chapter 2.2.25 introduce stricter performance requirements for UV-Vis spectrophotometers. Qualification across wavelength range, absorbance accuracy, stray light and resolution is essential for ensuring reliable analytical results in pharmaceutical, quality control and research laboratories.

Aims and Study Overview

This application note examines how the Agilent Cary 60 and Cary 3500 UV-Vis spectrophotometers satisfy the revised pharmacopeial guidelines effective December 2019 and January 2020. It outlines qualification procedures, evaluates instrument performance against new test limits, and highlights compliance support features.

Methodology and Instrumentation

Qualification tests cover:

• Wavelength accuracy and reproducibility using source line standards, holmium oxide, didymium and cerium sulfate filters
• Photometric accuracy, reproducibility and linearity with potassium dichromate, NIST glass filters, nicotinic acid and other reference materials
• Stray light assessment via ratio and maximum absorbance/minimum transmittance methods using potassium chloride, acetone, sodium iodide and nitrate
• Resolution verification using toluene/hexane mixtures

The Cary 60 and Cary 3500 systems employ a proprietary xenon flash lamp, featuring over ten years of operational life, rapid warm-up, extended photometric range and fast scanning. Qualification services and software tools adhere to 21 CFR Part 11, EU Annex 11 and ISO 9001 requirements.

Main Results and Discussion

Both instruments consistently meet or exceed updated wavelength and photometric criteria. Stray light and resolution tests demonstrate stable performance within pharmacopeial limits. Optional compliance software streamlines electronic records, signatures and audit trails. Quality-assured development of qualification routines ensures reliable execution and reporting.

Benefits and Practical Applications

• Assured compliance with global pharmacopeias and regulatory standards
• Reduced downtime and maintenance costs due to long-life xenon lamp
• Improved laboratory throughput through rapid scans and automated qualification routines
• Enhanced data integrity with secure software supporting electronic records

Future Trends and Potential Applications

Integration of cloud-based data management and remote qualification workflows will further simplify compliance. Advances in automated diagnostics and predictive maintenance are expected. Expanded use of chemometric tools may enhance spectral data interpretation and extend application scope into emerging fields such as nanomaterials and biopharmaceutical analysis.

Conclusion

The Agilent Cary 60 and 3500 UV-Vis spectrophotometers fully address the enhanced requirements of USP <857> and Ph. Eur. 2.2.25. Their robust design, comprehensive qualification procedures and compliant software support make them valuable assets for regulated laboratories seeking reliable, efficient and future-ready UV-Vis solutions.

Reference

• United States Pharmacopeia General Chapter <857> – Ultraviolet-Visible Spectroscopy
• European Pharmacopoeia Chapter 2.2.25 (10th Edition) – UV and Visible Spectrophotometry